Modified release dosage form with two cores

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/28 (2006.01) A61K 9/00 (2006.01) A61K 9/20 (2006.01)

Patent

CA 2499882

The invention provides a dosage form comprising at least one active ingredient, and first core and second cores surrounded by and separated by a shell. The dosage form provides a delay of at least one hour between the initial release of active ingredient contained in said first core and the initial release of active ingredient contained in said second core after contacting of the dosage form with a liquid medium.

La présente invention concerne une forme posologique comprenant au moins un principe actif, et deux noyaux distincts entourés par une coque les séparant l'un de l'autre. Cette forme posologique assure un décalage d'au moins une heure entre le début de libération du principe actif du premier noyau et le début de libération du principe actif du deuxième noyau une fois que la forme posologique a été mise en contact d'un milieu liquide.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Modified release dosage form with two cores does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified release dosage form with two cores, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified release dosage form with two cores will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1447998

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.